India-Delaware Biomanufacturing Partnership Proposed
Analysis based on 8 articles · First reported Mar 01, 2026 · Last updated Mar 03, 2026
The proposed India-United States===Delaware partnership is expected to positively impact the biotechnology and pharmaceutical markets by fostering co-development of affordable biologics and vaccines. This collaboration could also strengthen global health supply chains and accelerate innovation, benefiting both India and United States===Delaware's economies.
Union Minister for Science and Technology, Jitendra Singh, proposed a structured India-United States===Delaware partnership in advanced biomanufacturing during a meeting with United States===Delaware Governor Matt Meyer. The discussions focused on bilateral collaboration in pharmaceuticals, biotechnology, clean energy, and innovation-led industrial growth. Both sides agreed to form a working group to translate these discussions into concrete collaborations, including joint research, manufacturing, and startup ecosystem linkages. India highlighted its capabilities in cost-efficient manufacturing and its integrated innovation architecture, while United States===Delaware emphasized its biopharmaceutical manufacturing base and business-friendly environment. This engagement marks a new state-level dimension in the broader India-US strategic partnership, with a focus on strengthening global health supply chains and accelerating innovation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard